Skip to main
LSB
LSB logo

LSB Earnings Dates & Reports

LSB Most Recent Earnings

Report DateAug 15, 2024
Period EndingQ4 2024
Est. EPS-$0.90
Actual EPS-$1.90
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

LSB Earnings per Share (EPS) History

Signup for full access
Browse free

LSB Latest Earnings

The value each LSB share was expected to gain vs. the value each share gained.

LSB reported its most recent earnings on Aug 15, 2024 for Q4 2024, posting earnings per share (EPS) of -$1.90. This exceeded analysts' expectations of -$0.90 by 111.11%, marking a Miss.

For comparison, LakeShore Biopharma Co., Ltd reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 08/15/2024, with analysts projecting an EPS of $0.

LSB Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2024Aug 15, 2024
-$0.90-$1.90+111.11%
DeckReportListen
Q3 2024Apr 19, 2024
-$0.70-$1.20+71.43%
Q2 2024Jan 22, 2024
-$0.80-$1.60+100.00%
Q1 2024Aug 15, 2023
-$1.00

LSB Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the LakeShore Biopharma Co., Ltd’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Apr 19, 2024
Jan 22, 2024
Aug 15, 2023

LSB Earnings FAQs

LSB last reported earnings on Aug 15, 2024 for Q4 2024, posting an EPS of -$1.90, which Miss the estimate of -$0.90 by 111.11%.

For Q4 2024, LSB reported an EPS of -$1.90, missing analysts' estimate of -$0.90 by 111.11%.

For Q4 2024, LSB Miss expectations with an actual EPS of -$1.90 vs. an estimated EPS of -$0.90.

Following the last earnings report on Aug 15, 2024, LSB's stock price moved — from — to —.

The next LSB earnings call is scheduled for Aug. 15, 2024, where executives will discuss financial results and outlook.

LakeShore Biopharma Co., Ltd (LSB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.